CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +706 | $141.60 | $100K | 19,370.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +7,151 | $141.60 | $1.0M | 26,521.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +560 | $178.26 | $100K | 27,081.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +5,865 | $178.26 | $1.0M | 32,946.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −500 | $508.96 | $254K | 32,446.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −2,545 | $509.32 | $1.3M | 29,901.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −6,186 | $510.38 | $3.2M | 23,715.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −3,318 | $510.47 | $1.7M | 20,397.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −7,473 | $511.03 | $3.8M | 12,924.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Sale | −2,887 | $511.22 | $1.5M | 10,037.99 |
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,627 | 0 | ||
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −7,151 | 0 | ||
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −5,865 | 0 | ||
| 2023-08-15 | AYERS JONATHAN W Director | Sale | −492 | 135,547 | ||
| 2023-08-11 | AYERS JONATHAN W Director | Gift | −1,000 | 136,039 | ||
| 2023-08-05 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise | +192 | 29,809.35 | ||
| 2023-08-05 | MCKEON BRIAN P EVP, CFO and Treasurer | Shares withheld for taxes | −117 | $504.08 | $59K | 29,692.35 |
| 2023-08-05 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise · Restricted Stock Unit | −192 | 3,704 |
Page 40 of 52 · 1,036 trades